Pharmacy+Me | Weight Management
Patient guidance

Switching between Mounjaro and Wegovy

Some patients may switch between Mounjaro® (tirzepatide) and Wegovy® (semaglutide) for reasons such as availability, side effects, treatment response, cost, or clinical suitability.

There is no exact dose-for-dose conversion between Mounjaro and Wegovy because they are different medicines. The table below is a general estimated guide only. The most appropriate starting dose after switching will depend on:

  • the last dose you injected
  • how long it has been since your last injection
  • whether you had any side effects, such as nausea, vomiting, diarrhoea, constipation, reflux, abdominal pain, or reduced appetite
  • how well you tolerated previous dose increases
  • your clinician's assessment of what is safest for you

Both medicines are usually injected once weekly and are increased gradually to help improve tolerability. Mounjaro is normally increased in 2.5 mg steps at intervals of at least 4 weeks, up to a maximum of 15 mg once weekly. Wegovy is also increased gradually through the usual 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg weekly schedule.

Source: European Medicines Agency (EMA) product information.

Approximate equivalence

Current Mounjaro doseApproximate Wegovy equivalent
Mounjaro 2.5 mgWegovy 0.25 mg or 0.5 mg
Mounjaro 5 mgWegovy 1 mg
Mounjaro 7.5 mgWegovy 1.7 mg
Mounjaro 10 mgWegovy 2.4 mg
Mounjaro 12.5 mgWegovy 2.4 mg
Mounjaro 15 mgWegovy 2.4 mg

This is an estimated guide only. Final dose decisions are made by your clinician.

Important note

This table is only an estimate and should not be used to switch treatment without clinical review. Some patients may need to restart at a lower dose, especially if they had side effects, have missed doses, or have had a treatment break.

For example, a patient who tolerated Mounjaro well and recently had their last injection may be considered for a higher Wegovy starting dose than someone who had significant nausea or vomiting. If side effects were difficult to manage, the clinician may recommend starting lower and increasing more gradually.

You should not use Mounjaro and Wegovy at the same time unless specifically instructed by a prescriber. Always follow the dose and timing advised by your clinician.

How switching works with us

1. Clinical review

You request a switch through your patient portal. Our prescriber reviews your dose history, tolerability, and clinical record.

2. Tailored starting dose

The prescriber decides the safest starting dose for you on the new medicine — using the table above as a guide, not a rule.

3. Ongoing monitoring

We monitor side effects and progress at every renewal. Doses are adjusted gradually to keep your treatment safe and effective.

Speak to a clinician about switching

Existing patient? Request a switch from your portal. New to us? Start your assessment and we'll review your treatment history.